Epigenetic Influences on Post-Surgical Acute and Chronic Pain
An Exploratory Study of the Epigenetic Influences on Post-Surgical Acute and Chronic Pain
1 other identifier
observational
120
1 country
2
Brief Summary
Pain is the way our brain interprets certain bodily sensations. It is very difficult to describe or to put into words as perception and tolerance of pain varies widely between individuals. It is known that age, gender and past experience and memory of past experience all contribute to patients' feelings of discomfort and tolerance of pain, but the reason why some patients actually do not experience any pain at all post surgery is still unknown. Because pain affects every person at some point in their lives, it is of utmost importance that we can find more effective analgesic methods, and provide analgesia tailored to an individual's need as well as discovering new methods which may be able to identify those individuals who are more prone to suffering serious, or chronic pain. It has been proposed that epigenetic modifications may play a role in sensitivity to analgesia and response to trauma, such as post surgery. The effects of epigenetic changes on key genes and the role this plays in analgesia sensitivity and pain perception is deserving of further research. Epigenetics is a growing field of study in which there are genetic modifications that do not involve changes to base sequences in a gene, but that result nonetheless in changes to gene expression. It has long been known that changes in gene expression play an important role in the establishment of pain states. But it is not known whether a priming injury can induce lasting epigenetic marks which would result in an increase in both postoperative acute pain and the risk for chronic pain. Only by fully understanding these epigenetic mechanisms will we be able to offer better drugs for the treatment of pain, and to identify those at high risk of postoperative pain and postsurgical chronic pain. The purpose of this study is to determine whether severity of pain following surgical procedures, such as third molar surgery is related to baseline methylation status of the promoter region of IL-6 and TNF-α and changes in methylation status post surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2014
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2013
CompletedFirst Posted
Study publicly available on registry
December 6, 2013
CompletedStudy Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedJanuary 22, 2014
January 1, 2014
8 months
November 30, 2013
January 21, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
pain score
From postoperative 1 hour to postoperative 3 months
Secondary Outcomes (1)
IL-6 and TNF-α expression
From postoperative 1 hr to postoperative 3 month
Study Arms (2)
case group
patients undergo third molar surgery
control group
subjects do not require surgery
Eligibility Criteria
Subjects at Prince Philip Dental Hospital and Queen Mary Hospital
You may qualify if:
- Patient requires third molar surgery for case group and patient does not require surgery for control group
- Age 18 or above
- Ability to read and understand the study information and consent form
- Written consent obtained
You may not qualify if:
- Patient does not requires third molar surgery for case group and patient requires third molar surgery for control group
- Age below 18
- Major cognitive or psychiatric disorders that affect the ability to complete study
- Refuse to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Department of Anaesthesiology, The University of Hong Kong
Hong Kong, 0000, Hong Kong
Department of Anaesthesiology, The University of Hong Kong
Hong Kong, 0000, Hong Kong
Biospecimen
RNA and DNA
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chi W Cheung
Department of Anaesthesiology, The University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 30, 2013
First Posted
December 6, 2013
Study Start
January 1, 2014
Primary Completion
September 1, 2014
Study Completion
November 1, 2014
Last Updated
January 22, 2014
Record last verified: 2014-01